Background Familial hypercholesterolemia (FH) is an autosomal dominant disease that primarily results from mutations in the low-density lipoprotein receptor (LDLR) gene. We investigated two unrelated Chinese FH patients using gene screening and functional analysis to reveal the pathogenicity and the mechanism by which these mutations cause FH. Methods First, the LDLR gene was sequenced in these patients. Then, mutant receptors were transfected into human embryo kidney 293(HEK-293) cells, and a confocal laser-scanning microscope was used to observe the localization of mutant proteins. Further, the expression and the internalization activity were analyzed by flow cytometry. Finally, LDLR protein expression and stability was detected by western blot. Results Two different LDLR class 2B mutations were detected in two patients. The C201F mutation is a known mutation. However, the G615V mutation is novel. Flow cytometry showed that the expression and internalization activity of the mutant LDLRs were reduced to 73.6% and 82.6% for G615V and 33.2% and 33.5% for C201F, respectively. Conclusions This study identified two LDLR mutations in Chinese patients with FH and analyzed the relationship between the genotype and phenotype of these patients. We found that these mutant LDLRs were defective in transport, which led to a reduction in cholesterol clearance. These results increase our understanding of the mutational spectrum of FH in the Chinese population.
References
[1]
Leren TP, Berge KE (2011) Subjects with molecularly defined familial hypercholesterolemia or familial defective apoB-100 are not being adequately treated. PLoS One 6: e16721. doi: 10.1371/journal.pone.0016721
[2]
Goldstein JL, Hobbs HH, Brown MS (2001) Familial hypercholesterolemia. In: Scriver CR, Baudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. New Yrok: McGraw-Hill. 2863–2913.
[3]
Austin MA, Hutter CM, Zimmern RL, Humphries SE (2004) Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol 160: 407–420. doi: 10.1093/aje/kwh236
[4]
Marais AD (2004) Familial hypercholesterolaemia. Clin Biochem Rev 25: 49–68.
[5]
Soutar AK, Naoumova RP (2007) Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med 4: 214–225. doi: 10.1038/ncpcardio0836
[6]
Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG (2012) Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab 97: 3956–3964. doi: 10.1210/jc.2012-1563
[7]
Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, et al.. (2013) Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society. Eur Heart J.
[8]
Moorjani S, Roy M, Gagne C, Davignon J, Brun D, et al. (1989) Homozygous familial hypercholesterolemia among French Canadians in Quebec Province. Arteriosclerosis 9: 211–216. doi: 10.1161/01.atv.9.2.211
[9]
Rader DJ, Cohen J, Hobbs HH (2003) Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J Clin Invest 111: 1795–1803. doi: 10.1172/jci18925
[10]
Jeon H, Blacklow SC (2005) Structure and physiologic function of the low-density lipoprotein receptor. Annu Rev Biochem 74: 535–562. doi: 10.1146/annurev.biochem.74.082803.133354
[11]
Hobbs HH, Brown MS, Goldstein JL (1992) Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1: 445–466. doi: 10.1002/humu.1380010602
[12]
Gent J, Braakman I (2004) Low-density lipoprotein receptor structure and folding. Cell Mol Life Sci 61: 2461–2470. doi: 10.1007/s00018-004-4090-3
[13]
Hobbs HH, Russell DW, Brown MS, Goldstein JL (1990) The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. Annu Rev Genet 24: 133–170. doi: 10.1146/annurev.ge.24.120190.001025
[14]
Usifo E, Leigh SE, Whittall RA, Lench N, Taylor A, et al. (2012) Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment. Ann Hum Genet 76: 387–401. doi: 10.1111/j.1469-1809.2012.00724.x
[15]
Naoumova RP, Neuwirth C, Pottinger B, Whittal R, Humphries SE, et al. (2004) Genetic diagnosis of familial hypercholesterolaemia: a mutation and a rare non-pathogenic amino acid variant in the same family. Atherosclerosis 174: 67–71. doi: 10.1016/j.atherosclerosis.2004.01.001
[16]
Silva S, Alves AC, Patel D, Malho R, Soutar AK, et al. (2012) In vitro functional characterization of missense mutations in the LDLR gene. Atherosclerosis 225: 128–134. doi: 10.1016/j.atherosclerosis.2012.08.017
[17]
Lin J, Wang LY, Liu S, Xia JH, Yong Q, et al. (2008) Functional analysis of low-density lipoprotein receptor in homozygous familial hypercholesterolemia patients with novel 1439 C–>T mutation of low-density lipoprotein receptor gene. Chin Med J (Engl) 121: 776–781.
[18]
Wang L, Lin J, Liu S, Cao S, Liu J, et al. (2009) Mutations in the LDL receptor gene in four Chinese homozygous familial hypercholesterolemia phenotype patients. Nutr Metab Cardiovasc Dis 19: 391–400. doi: 10.1016/j.numecd.2008.07.011
[19]
Sorensen S, Ranheim T, Bakken KS, Leren TP, Kulseth MA (2006) Retention of mutant low density lipoprotein receptor in endoplasmic reticulum (ER) leads to ER stress. J Biol Chem 281: 468–476. doi: 10.1074/jbc.m507071200
[20]
Fouchier SW, Defesche JC, Umans-Eckenhausen MW, Kastelein JP (2001) The molecular basis of familial hypercholesterolemia in The Netherlands. Hum Genet 109: 602–615. doi: 10.1007/s00439-001-0628-8
[21]
Leigh SE, Foster AH, Whittall RA, Hubbart CS, Humphries SE (2008) Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database. Ann Hum Genet 72: 485–498. doi: 10.1111/j.1469-1809.2008.00436.x
[22]
Beuret N, Stettler H, Renold A, Rutishauser J, Spiess M (2004) Expression of regulated secretory proteins is sufficient to generate granule-like structures in constitutively secreting cells. J Biol Chem 279: 20242–20249. doi: 10.1074/jbc.m310613200
[23]
Jeon H, Meng W, Takagi J, Eck MJ, Springer TA, et al. (2001) Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair. Nat Struct Biol 8: 499–504.
[24]
Rudenko G, Henry L, Henderson K, Ichtchenko K, Brown MS, et al. (2002) Structure of the LDL receptor extracellular domain at endosomal pH. Science 298: 2353–2358. doi: 10.1126/science.1078124
Russell DW, Brown MS, Goldstein JL (1989) Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins. J Biol Chem 264: 21682–21688.
[27]
Esser V, Limbird LE, Brown MS, Goldstein JL, Russell DW (1988) Mutational analysis of the ligand binding domain of the low density lipoprotein receptor. J Biol Chem 263: 13282–13290.
[28]
Civeira F, Ros E, Jarauta E, Plana N, Zambon D, et al.. (2008) Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia. Am J Cardiol 102: 1187–1193, 1193 e1181.
[29]
Palacios L, Grandoso L, Cuevas N, Olano-Martin E, Martinez A, et al. (2012) Molecular characterization of familial hypercholesterolemia in Spain. Atherosclerosis 221: 137–142. doi: 10.1016/j.atherosclerosis.2011.12.021
